PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

ConditionsProstate Cancer Biochemical Relapse Fo Malignant Neoplasm of Prostate Prostate Adenocarcinoma Prostate Cancer Recurrent

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexMale

Age18+

SponsorAzienda Ospedaliero-Universitaria Careggi

About this trial

This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.

Eligibility criteria

Qualifiers

Signed informed consent

Age >18

Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA > 0.2 and <1

Disqualifiers

ADT administration within 6 months from study enrollment

Persistent elevation of PSA after RP measured within 16 weeks from surgery (> 0.1 ng/ml)

Trial design

Treatments tested in this trial

Not listed

Trial groups

180 Participants

are grouped into 1 trial group

Sponsors and collaborators

Azienda Ospedaliero-Universitaria Careggi

Lead sponsor

Source ClinicalTrials.gov